Serotonin signals through a gut-liver axis to regulate hepatic steatosis

Nonalcoholic fatty liver disease (NAFLD) is increasing in worldwide prevalence, closely tracking the obesity epidemic, but specific pharmaceutical treatments for NAFLD are lacking. Defining the key molecular pathways underlying the pathogenesis of NAFLD is essential for developing new drugs. Here we...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature communications Jg. 9; H. 1; S. 4824 - 9
Hauptverfasser: Choi, Wonsuk, Namkung, Jun, Hwang, Inseon, Kim, Hyeongseok, Lim, Ajin, Park, Hye Jung, Lee, Hye Won, Han, Kwang-Hyub, Park, Seongyeol, Jeong, Ji-Seon, Bang, Geul, Kim, Young Hwan, Yadav, Vijay K., Karsenty, Gerard, Ju, Young Seok, Choi, Chan, Suh, Jae Myoung, Park, Jun Yong, Park, Sangkyu, Kim, Hail
Format: Journal Article
Sprache:Englisch
Veröffentlicht: London Nature Publishing Group UK 16.11.2018
Nature Publishing Group
Nature Portfolio
Schlagworte:
ISSN:2041-1723, 2041-1723
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!